4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-23-018530
Options or other derivatives
- Chief Financial Officer acquired 409,688 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Foster Jonathan P. Chief Financial Officer | 2023-06-22 | Grant or award · Stock option (right to buy) | +150,000 | 830,938 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2023-06-22 | Grant or award · Restricted Stock Units | +259,688 | 1,090,626 | D | ||
Loading xslF345X04/rdgdoc.xml…